Hemorrhagic Complications of Transvaginal Oocyte's Retrieval: an Update.
NCT ID: NCT05895227
Last Updated: 2023-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
13193 participants
OBSERVATIONAL
2017-01-01
2022-12-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Analysis of the Incidence of Complications From Transvaginal Oocyte Retrieval (TVOR).
NCT03282279
Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)
NCT06896617
Investigational Oocyte Cryopreservation for Medical and Non Medical Indications
NCT04616417
Is the AMH Intrafollicular Level a Predictor of the Ploidy Status of the Blastocyst?
NCT05837325
Endometrial Injury and in Vitro Fertilization Outcomes
NCT02153814
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All retrievals will be retrieved in IVF/ICSI cycles and Fertility Preservation both in oncological patients and in patients requesting oocyte storage for deferring motherhood.
Data collection goes from January 2017 to December 2022.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oocyte retrieval
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituto Clinico Humanitas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paolo Emanuele Levi Setti, M.D.
Role: PRINCIPAL_INVESTIGATOR
Istituto Clinico Humanitas
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16/23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.